United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Pharma Industry News What Sutro Biopharma’s restructuring says about biotech layoffs and investor sentiment in 2025 Sutro Biopharma (NASDAQ: STRO) slashes jobs and narrows its pipeline to extend cash runway into 2027. What does this restructuring mean for investors? byPallavi MadhirajuSeptember 30, 2025